Title : Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.

Pub. Date : 2004 Jun 15

PMID : 15217942






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EXPERIMENTAL DESIGN: We administered rituximab with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) treatment with G-CSF to 15 patients with follicular lymphoma, and we investigated the safety and efficacy of this regimen. Prednisone colony stimulating factor 3 Homo sapiens